MA43954A - Ligands d'imagerie tau-pet - Google Patents

Ligands d'imagerie tau-pet

Info

Publication number
MA43954A
MA43954A MA043954A MA43954A MA43954A MA 43954 A MA43954 A MA 43954A MA 043954 A MA043954 A MA 043954A MA 43954 A MA43954 A MA 43954A MA 43954 A MA43954 A MA 43954A
Authority
MA
Morocco
Prior art keywords
tau
pet imaging
imaging ligands
ligands
pet
Prior art date
Application number
MA043954A
Other languages
English (en)
Inventor
José Ignacio Andrés-Gil
Guy Maurits R Bormans
Vladimir Chupakhin
Lieven Denis Herwig Declercq
Katleen Fierens
Hartmuth Kolb
Joseph Elisabeth Leenaerts
Diederik Willem Elisabeth Moechars
Frederik Jan Rita Rombouts
Wei Zhang
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MA43954A publication Critical patent/MA43954A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nuclear Medicine (AREA)
MA043954A 2016-02-03 2017-02-01 Ligands d'imagerie tau-pet MA43954A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP16154123 2016-02-03
EP16161466 2016-03-21
EP16183009 2016-08-05
EP16186603 2016-08-31

Publications (1)

Publication Number Publication Date
MA43954A true MA43954A (fr) 2018-12-12

Family

ID=57963206

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043954A MA43954A (fr) 2016-02-03 2017-02-01 Ligands d'imagerie tau-pet

Country Status (9)

Country Link
US (2) US20190038784A1 (fr)
EP (1) EP3411083A1 (fr)
JP (1) JP6966456B2 (fr)
AU (1) AU2017216212B2 (fr)
CA (1) CA3010690A1 (fr)
EA (1) EA035621B1 (fr)
IL (1) IL260862B (fr)
MA (1) MA43954A (fr)
WO (1) WO2017134098A1 (fr)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2247558T3 (pl) * 2008-02-14 2022-05-02 Eli Lilly And Company Nowe środki obrazujące do wykrywania czynnościowych zaburzeń neurologicznych
WO2010111303A2 (fr) * 2009-03-23 2010-09-30 Siemens Medical Solutions Usa, Inc. Agents d'imagerie pour détecter des troubles neurologiques
WO2010143169A2 (fr) * 2009-06-12 2010-12-16 Société Splicos Composés s'utilisant dans le traitement du sida
US9138494B2 (en) * 2011-12-23 2015-09-22 Abbvie Inc. Radiolabeled PDE10A ligands
WO2015110263A1 (fr) * 2014-01-21 2015-07-30 Ac Immune Sa Composés de carbazole et de carboline destinés à être utilisés dans le diagnostic, le traitement, l'atténuation ou la prévention de troubles associés aux protéines amyloïdes et de type amyloïde

Also Published As

Publication number Publication date
US20210283277A1 (en) 2021-09-16
CA3010690A1 (fr) 2017-08-10
AU2017216212A1 (en) 2018-07-19
EA035621B1 (ru) 2020-07-16
US20190038784A1 (en) 2019-02-07
AU2017216212B2 (en) 2020-12-24
EP3411083A1 (fr) 2018-12-12
IL260862B (en) 2021-05-31
JP2019511461A (ja) 2019-04-25
WO2017134098A1 (fr) 2017-08-10
JP6966456B2 (ja) 2021-11-17
EA201891726A1 (ru) 2018-12-28

Similar Documents

Publication Publication Date Title
CL2017001762S1 (es) Cámara
MA45225A (fr) Complexes radiopharmaceutiques
DK3474804T4 (da) Medicinsk forbinding
FR3036037B1 (fr) Harnais d'encordement perfectionne
UY4562S (es) Cámara
CL2017001763S1 (es) Cámara
MA48596A (fr) Caractéristique d'inertie
MA43873A (fr) Dspositif d'injection
DK3438103T3 (da) Griseofulvinforbindelse
DK3512518T3 (da) Buprenophinformuleringer med langvarig frigivelse
DK3478788T3 (da) Inhiberet vandig afisningssammensætning
DK3436447T3 (da) Isoquinolinyl-triazolon-komplekser
JP2018526786A5 (fr)
ES1109830Y (es) " senalador de prendas"
ITUA20163609A1 (it) "micro-cogeneratore".
MA43954A (fr) Ligands d'imagerie tau-pet
FR3033711B3 (fr) Structure d'assemblage pour piste-jouet
MA51199A (fr) Agents d'imagerie
IT201700090331A1 (it) "lopemide"
IT201700071679A1 (it) Remembebe'
ITUA20163709A1 (it) "presentosa3d"
TH178766B (th) "กระเป๋า"
UA35666S (uk) Зображення для емблеми
ES1198410Y (es) La palillera
UA32431S (uk) Стрем'янка